SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-24-000639
Filing Date
2024-05-09
Accepted
2024-05-09 18:03:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3322
  Complete submission text file 0001972362-24-000639.txt   4831
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-33093 | Film No.: 24932245
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LIGAND PHARMACEUTICALS INCORPORATED 3911 SORRENTO VALLEY BOULEVARD, STE 110 SAN DIEGO CA 92121
Business Address
Gray Nancy Ryan (Reporting) CIK: 0001714949 (see all company filings)

Type: 144